Paraganglioma — Trials

Paraganglioma — Trials · CancerIndex

Clinical trials

Registered studies

144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04187404	A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma(Spencer)	terminated	Phase 1 / Phase 2	70	EnteromeINDUSTRY	8	Jan 30, 2026	clinicaltrials
NCT02177773	GA-68 DOTA-TOC of Somatostatin Positive Malignancies(DOTA-TOC)	terminated	Phase 1 / Phase 2	300	University of California, San FranciscoOTHER	1	Nov 12, 2019